Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8,435 | 3 | 69.9% |
| Food and Beverage | $3,576 | 125 | 29.7% |
| Consulting Fee | $50.00 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $8,880 | 26 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $561.75 | 23 | $0 (2024) |
| Alcon Vision LLC | $361.71 | 10 | $0 (2024) |
| Oyster Point Pharma, Inc. | $313.24 | 12 | $0 (2024) |
| Alcon Laboratories Inc | $276.09 | 7 | $0 (2018) |
| ABBVIE INC. | $247.28 | 6 | $0 (2024) |
| Ocular Therapeutix, Inc. | $222.65 | 5 | $0 (2022) |
| Aerie Pharmaceuticals, Inc. | $219.16 | 7 | $0 (2021) |
| Astellas Pharma US Inc | $139.06 | 2 | $0 (2024) |
| Glaukos Corporation | $125.60 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $612.51 | 22 | SUN PHARMACEUTICAL INDUSTRIES INC. ($152.86) |
| 2023 | $371.39 | 16 | Oyster Point Pharma, Inc. ($107.58) |
| 2022 | $573.44 | 22 | ABBVIE INC. ($195.44) |
| 2021 | $284.64 | 15 | Allergan, Inc. ($74.18) |
| 2020 | $8,688 | 12 | Allergan, Inc. ($8,463) |
| 2019 | $703.61 | 17 | Alcon Vision LLC ($280.74) |
| 2018 | $412.10 | 13 | Glaukos Corporation ($125.60) |
| 2017 | $415.69 | 12 | Alcon Laboratories Inc ($248.11) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Dry eyes | ||||||
| 09/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Ophthalmology | ||||||
| 09/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/20/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Dry eyes | ||||||
| 08/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| 07/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: SOLUTION/ DROPS | ||||||
| 05/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Ophthalmology | ||||||
| 04/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Ophthalmology | ||||||
| 04/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/16/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Dry eyes | ||||||
| 02/27/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: SOLUTION/ DROPS | ||||||
| 02/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: EYE CARE | ||||||
| 02/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $120.84 | General |
| Category: Ophthalmology | ||||||
| 01/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Ophthalmology | ||||||
| 11/07/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: DRY EYE | ||||||
| 10/18/2023 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Soft Contact Lenses | ||||||
| 09/25/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Immunology and Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Multicenter Double Masked Randomized Vehicle-Controlled Parallel-Group study of AGN-190584 for Participants with Presbyopia | Allergan, Inc. | $8,435 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,814 | 4,176 | $543,110 | $259,824 |
| 2022 | 15 | 2,749 | 4,099 | $571,980 | $270,518 |
| 2021 | 15 | 2,628 | 3,909 | $500,730 | $248,409 |
| 2020 | 14 | 2,349 | 3,378 | $413,125 | $206,772 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 936 | 1,316 | $190,820 | $101,204 | 53.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 78 | 118 | $106,200 | $47,526 | 44.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 153 | 319 | $31,900 | $18,871 | 59.2% |
| 65756 | Transplantation of outer layer of corneal tissue | Facility | 2023 | 15 | 18 | $44,250 | $15,717 | 35.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 45 | 61 | $27,450 | $14,766 | 53.8% |
| 92285 | Photography of content of eyes | Office | 2023 | 292 | 737 | $25,795 | $10,983 | 42.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 117 | 117 | $20,475 | $10,346 | 50.5% |
| 92134 | Imaging of retina | Office | 2023 | 277 | 393 | $19,650 | $10,157 | 51.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 199 | 230 | $17,250 | $9,362 | 54.3% |
| 92025 | Ct scan of cornea | Office | 2023 | 156 | 253 | $12,650 | $5,487 | 43.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 211 | 246 | $12,300 | $5,470 | 44.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 188 | 191 | $21,010 | $5,184 | 24.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 97 | 120 | $6,000 | $1,909 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 28 | $4,200 | $1,740 | 41.4% |
| 65430 | Scraping of cornea for diagnosis | Office | 2023 | 12 | 13 | $2,600 | $999.35 | 38.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 13 | 16 | $560.00 | $104.52 | 18.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 926 | 1,307 | $189,575 | $99,650 | 52.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 92 | 148 | $132,700 | $59,034 | 44.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 163 | 365 | $36,500 | $21,558 | 59.1% |
| 65756 | Transplantation of outer layer of corneal tissue | Facility | 2022 | 19 | 22 | $55,000 | $19,158 | 34.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 46 | 63 | $28,350 | $14,516 | 51.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 118 | 118 | $20,650 | $10,412 | 50.4% |
| 92285 | Photography of content of eyes | Office | 2022 | 281 | 722 | $25,270 | $10,290 | 40.7% |
| 92134 | Imaging of retina | Office | 2022 | 280 | 384 | $19,200 | $9,833 | 51.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 199 | 222 | $16,650 | $9,265 | 55.6% |
About Dr. John Meyer, MD
Dr. John Meyer, MD is a Ophthalmology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588750681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Meyer, MD has received a total of $12,061 in payments from pharmaceutical and medical device companies, with $612.51 received in 2024. These payments were reported across 129 transactions from 28 companies. The most common payment nature is "" ($8,435).
As a Medicare-enrolled provider, Meyer has provided services to 10,540 Medicare beneficiaries, totaling 15,562 services with total Medicare billing of $985,523. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Louisville, KY
- Active Since 10/05/2006
- Last Updated 09/06/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1588750681
Products in Payments
- Cequa (Drug) $382.96
- TYRVAYA (Drug) $313.24
- DURYSTA (Drug) $288.53
- ReSTOR (Device) $266.13
- CEQUA (Drug) $168.23
- DEXTENZA (Drug) $156.87
- LUMIGAN (Drug) $153.31
- Rhopressa (Drug) $150.99
- PanOptix (Device) $128.30
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $125.60
- XDEMVY (Drug) $122.01
- Izervay (Drug) $120.84
- INVELTYS (Drug) $119.70
- XIIDRA (Drug) $118.32
- ORA (Device) $106.71
- rhopressa (Drug) $68.64
- ReSure Sealant (Device) $65.78
- OXERVATE (Drug) $51.72
- VUITY (Drug) $51.02
- Acuvue (Device) $49.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Louisville
Dr. Brennan Greene, Md, MD
Ophthalmology — Payments: $154,528
Guruprasad Pattar, M.d, M.D
Ophthalmology — Payments: $93,365
Dr. Thomas Stone, M.d, M.D
Ophthalmology — Payments: $69,343
Dr. George John, Md, MD
Ophthalmology — Payments: $30,207
Dr. Richard Eiferman, Md, MD
Ophthalmology — Payments: $14,887
Christopher Compton, M.d, M.D
Ophthalmology — Payments: $13,482